SIRT2 and cancer: HRD1 knockdown via shRNA appeared to inhibit the proliferation of A549 and H446 cancer cells (Fig. 5B and Fig. S2B), while SIRT2 overexpression or knockdown led to the reverse result (Fig. 5A and B and Fig. S2A and B).